The efficacy of Landiolol Administration for Prevention of Atrial Fibrillation after Proximal Aortic Surgery

Landiolol for Prevention of Atrial Fibrillation after Proximal Aortic Surgery - Landiolol for POAF after proximal aortic surgery

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000043692

Enrollment

250

Registered

2021-03-22

Start date

2019-04-11

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

the aneurysm of aortic root, ascending aorta, or aortic arch/the dissection of proximal aorta

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients more than 18 years old without preoperative AF who underwent proximal aortic surgery at Hiroshima City Hospital between January 1, 2011, and December 31, 2018

Exclusion criteria

Exclusion criteria: preoperative AF CABG or valve surgery performed with aortic surgery missing data

Design outcomes

Primary

Measure	Time frame
reduction of the incidence of new-onset POAF that occurred within 72 hrs after operation	—

Secondary

Measure	Time frame
30-day mortality, 30-day symptomatic cerebral infarction, length of hospital stay (days), length of ICU stay (days), length of mechanical ventilation (hours), need for pacemaker support (using pacemaker for stability of hemodynamics), and average of mean BP and HR during 72 hrs after ICU admission	—

Countries

Japan

Contacts

Public ContactMakoto Takatori

Hiroshima City Hospital Department of Anesthesia and Intensive care

takatori@ksj.biglobe.ne.jp082-221-2291

Outcome results